Kris Carlson

Just another WordPress.com weblog

Cancer control through apoptosis control

A problem for efficacious gene therapy has been identifying the control region for the gene to be transferred along with the gene. Here they not only identified a control region, bax, of the target gene, survivin, but mutated it to increase downregulation of the target, which is only expressed in developmental cells and consequently is ideal for cancer treatment. Survivin is an apoptosis inhibitor, so downregulating it allows the cancer cell-killing pathways to become active.

“The survivin protein is expressed highly in most human tumours and fetal tissue, but is completely absent in terminally differentiated cells.[3] This fact therefore makes survivin an ideal target for cancer therapy as cancer cells are targeted while normal cells are left alone.” (Wikipedia citing Sah NK, Khan Z, Khan GJ, Bisen PS (December 2006). “Structural, functional and therapeutic biology of survivin”. Cancer Lett. 244 (2): 164–71.doi:10.1016/j.canlet.2006.03.007PMID 16621243)

http://ttc.nci.nih.gov/opportunities/opportunity.php?opp_id=601

IF bax works similarly in humans, this will be tried for suppression of brain tumors. Likewise, we could look for bax downregulation as a cause of cancer in aging humans.

http://www.ncbi.nlm.nih.gov/pubmed/16619663

November 3, 2010 - Posted by | Biogerontology | , , , , ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: